In addition, Ang-II-infused Syn-hACE2 mice presented with reduced cardiac hypertrophy and enhanced hACE2 expression was shown to counter ADAM17-mediated shedding of the enzyme from the plasma membrane, resulting in enhanced clearance of Ang-II and reduced AT1R signaling. The gene discussed is AGT; the disease is cardiac hypertrophy.